PD-1 can be also expressed in TILs and, on the other hand, tumor cells can express PD‐L1 in different percentage, contributing to the inhibition of CD4+ and CD8+ T-cell activation and to the apoptosis of antigen-specific T-cell clones (83, 84). Here, CD4 is linked to neoplasm.